AGITG 2013* David Kerr
University of Oxford, , United Kingdom
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Using Molecular markers to improve trial efficiency (10244)
1:30 PM
David Kerr
Update on adjuvant therapy
EGFR-inhibitors in metastatic colorectal cancer – who, when and why? (10490)
8:00 AM
David Kerr
Meet the Professor Breakfast Symposium - sponsored by Merck Serono
How can we do trials more effectively?: An international perspective (10541)
9:00 AM
David Kerr
AGITG Plenary - sponsored by Merck Serono